Skip to main content

Table 3 Timing of use with regards to administration route categories, cannabis sub-types, and cannabinoids

From: A mixed methods analysis of cannabis use routines for chronic pain management

  AM PM Afternoon As needed Throughout the day Uncertain Total
Subgroups
Inhalation 146 (10.8%) 496 (36.7%) 71 (5.3%) 211 (15.6%) 337 (24.9%) 91 (6.7%) 1352
Non-inhalation 210 (19.4%) 377 (34.7%) 63 (5.8%) 168 (15.5%) 160 (14.7%) 107 (9.9%) 1085
Cannabis subtypes
Indica 6 (2.7%) 177 (80.8%) 5 (2.3%) 13 (5.9%) 11 (5.0%) 7 (3.2%) 219
Sativa 46 (32.2%) 10 (7.0%) 14 (9.8%) 14 (9.8%) 53 (37.1%) 6 (4.2%) 143
Hybrid 4 (6.5%) 19 (30.6%) 11 (17.7%) 5 (8.1%) 19 (30.6%) 4 (6.5%) 62
Cannabinoids
CBD 128 (27.3%) 100 (21.3%) 31 (6.6%) 56 (11.9%) 118 (25.2%) 36 (7.7%) 469
THC 44 (12.0%) 179 (48.9%) 15 (4.1%) 49 (13.4%) 59 (16.1%) 20 (5.5%) 366
1:1 CBD:THC 15 (21.1%) 20 (28.2%) 8 (11.3%) 8 (11.3%) 18 (25.4%) 2 (2.8%) 71
Unknown cannabinoids 184 (13.3%) 504 (36.3%) 82 (5.9%) 219 (15.8%) 278 (20.0%) 121 (8.7%) 1388
  1. Timing of administration route categories, chemovars, and cannabinoids. Smoking and vaping were categorized as “inhalation,” while edibles, tinctures, and topicals were categorized as “non-inhalation.” “Other” and “Concentrates” were not subgrouped into inhalation or non-inhalation categories.
  2. AM morning, PM evening